The new 500,000ft2 facility will provide 128 beds for cancer patients, which will allow University of Chicago Medicine to open other beds for patients with other complex or acute care needs in areas such as cardiology, digestive diseases, organ transplants, trauma care, and orthopaedics.
This will help to address capacity issues of the medical centre.
The facility will be the first freestanding clinical cancer centre in the city that will include both inpatient and outpatient care.
UChicago Medicine has filed a certificate of need (CON) request to the Illinois Health Facilities and Services Review Board for permission to spend money on the design and site planning for the new facility.
The healthcare centre stated that the new freestanding clinical cancer centre will also address healthcare inequities for residents of the South Side, who have less access to healthcare.
University of Chicago Medicine Comprehensive Cancer Center director Kunle Odunsi said: “Cancer death rates on the South Side are almost twice the national average, and cancer is the second-leading cause of death for area residents.
“This is one of the key reasons we are building this cancer center. Social determinants of health are not only linked to adverse environmental exposures but also to a lack of resources, including access to disease prevention, early detection and high-quality cancer care.”
Upon receipt of regulatory approval, construction work of the new cancer centre will commence in 2023. The centre will open in 2026.
The project is anticipated to create over 500 jobs during the construction phase.